Validation of immunocytochemistry as a morphomolecular technique

Cancer Cytopathology

Volumn 124, Issue 8, 2016, Pages 540-545

  Maxwell, Perry ^a   Salto Tellez, Manuel ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

immunocytochemistry; molecular diagnostics; morphomolecular; test validation

Indexed keywords

ANALYTIC METHOD; ANTIBODY DETECTION; CLINICAL LABORATORY; CLINICAL PROTOCOL; CONFLICT OF INTEREST; CYTOLOGY; FUNDING; HUMAN; IMMUNOCYTOCHEMISTRY; METHODOLOGY; MOLECULAR DIAGNOSIS; MORPHOMOLECULAR TECHNIQUE; NOTE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REPRODUCIBILITY; VALIDATION PROCESS;

EID: 84982165922     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21692     Document Type: Note

References (26)

1. McCourt CM, Boyle D, James J, Salto-Tellez M. Immunohistochemistry in the era of personalised medicine. J Clin Pathol. 2013;66:58–61.
2. Salto-Tellez M, Koay ES. Molecular diagnostic cytopathology: definitions, scope and clinical utility. Cytopathology. 2004;15:252–255.
3. Salto-Tellez M. Diagnostic molecular pathology—a further decade of progress. Cytopathology. 2015;26:269–270.
4. Sauter JL, Ambaye AB, Mount SL. Increased utilization, verification, and clinical implications of immunocytochemistry: experience in a northern New England hospital. Diagn Cytopathol. 2015;43:688–695.
5. Fitzgibbons PL, Bradley LA, Fatheree LA, et al. Principles of analytic validation of immunohistochemical assays: guideline from the College of American Pathologists Pathology and Laboratory Quality Center. Arch Pathol Lab Med. 2014;138:1432–1443.
6. Bueno Angela SP, Viero RM, Soares CT. Fine needle aspirate cell blocks are reliable for detection of hormone receptors and HER-2 by immunohistochemistry in breast carcinoma. Cytopathology. 2013;24:26–32.
7. Kirbis IS, Maxwell P, Flezar MS, Miller K, Ibrahim M. External quality control for immunocytochemistry on cytology samples: a review of UK NEQAS ICC (cytology module) results. Cytopathology. 2011;22:230–237.
8. Maxwell P, Patterson AH, Jamison J, Miller K, Anderson N. Use of alcohol fixed cytospins protected by 10% polyethylene glycol in immunocytology external quality assurance. J Clin Pathol. 1999;52:141–144.
9. Yang H, Zhao H, Garfield DH, Teng J, Han B, Sun J. Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of non-lymph node thoracic lesions. Ann Thorac Med. 2013;8:14–21.
10. Sanz-Santos J, Cirauqui B, Sanchez E, et al. Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of intrathoracic lymph node metastases from extrathoracic malignancies. Clin Exp Metastasis. 2013;30:521–528.
11. Navani N, Nankivell M, Lawrence DR, et al. Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial. Lancet Respir Med. 2015;3:282–289.
12. Collins BT. Endobronchial ultrasound fine-needle aspiration biopsy of pulmonary non-small cell carcinoma with subclassification by immunohistochemistry panel. Cancer Cytopathol. 2013;121:146–154.
13. Barr-Fritcher EG, Kipp BR, Halling KC, Clayton AC. FISHing for pancreatobiliary tract malignancy in endoscopic brushings enhances the sensitivity of routine cytology. Cytopathology. 2014;25:288–301.
14. Bongiovanni M, Molinari F, Eszlinger M, et al. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience. Cytopathology. 2015;26:288–296.
15. Capelli L, Marfisi C, Puccetti M, et al. Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples. Cytopathology. 2015;26:297–302.
16. Addati T, Achille G, Centrone M, et al. TROP-2 expression in papillary thyroid cancer: a preliminary cyto-histological study. Cytopathology. 2015;26:303–311.
17. Pagni F, Mainini V, Garancini M, et al. Proteomics for the diagnosis of thyroid lesions: preliminary report. Cytopathology. 2015;26:318–324.
18. Elliott K, McQuaid S, Salto-Tellez M, Maxwell P. Immunohistochemistry should undergo robust validation equivalent to that of molecular diagnostics. J Clin Pathol. 2015;68:766–770.
19. Mattocks CJ, Morris MA, Matthijs G, et al. A standardized framework for the validation and verification of clinical molecular genetic tests. Eur J Hum Genet. 2010;18:1276–1288.
20. Bordeaux J, Welsh A, Agarwal S. et al. Antibody validation. Biotechniques. 2010;48:197–201.
21. Mohd Omar MF, Huang N, Ou K, et al. Molecular-assisted immunohistochemical optimization. Acta Histochem. 2010;112:519–528.
22. Maxwell P, McCluggage WG. Audit and internal quality control in immunohistochemistry. J Clin Pathol. 2000;53:929–932.
23. Kirbis IS, Krasovec MU, Pogacnik A, Flezar MS. Optimization and validation of immunocytochemical detection of oestrogen receptors on cytospins prepared from fine needle aspiration (FNA) samples of breast cancer. Cytopathology. 2015;26:88–98.
24. Catherwood MA, Schmitt F, Salto-Tellez M. Molecular diagnostics and the training of future tissue- and cell-based pathologists. Cytopathology. 2012;23:283–285.
25. Flynn C, James J, Maxwell P, et al. Integrating molecular diagnostics into histopathology training: the Belfast model. J Clin Pathol. 2014;67:632–636.
26. Salto-Tellez M. A case for integrated morphomolecular diagnostic pathologists. Clin Chem. 2007;53:1188–1190.